Yannan Lian

320 Yueyang Road
Yueyang, 200031, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Proteogenomic Characterization Reveals Metabolic Vulnerabilities and Aberrant Phosphorylation in Colorectal Metastasis to Liver.

Proteogenomic Characterization Reveals Metabolic Vulnerabilities and Aberrant Phosphorylation in Colorectal Metastasis to Liver.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 27, 2025

Chemotherapy triggers immune evasion by fostering LEPR+ Kupffer cell differentiation in liver metastases.

Chemotherapy triggers immune evasion by fostering LEPR+ Kupffer cell differentiation in liver metastases.

Journal: Cancer cell
Published: March 22, 2025

KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy.

KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy.

Journal: Cancer cell
Published: May 29, 2024

Vagal pathway activation links chronic stress to decline in intestinal stem cell function.

Vagal pathway activation links chronic stress to decline in intestinal stem cell function.

Journal: Cell stem cell
Published: May 08, 2024

Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer.

Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer.

Journal: Nature cancer
Published: February 01, 2024

Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer.

Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer.

Journal: Cancer cell
Published: September 22, 2022

ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression.

ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression.

Journal: Nature communications
Published: March 18, 2022

Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ-stimulated antitumor immunity.

Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ-stimulated antitumor immunity.

Journal: The Journal of clinical investigation
Published: July 14, 2021

The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability.

The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability.

Journal: Molecular cell
Published: July 08, 2020
Showing 1-9 of 9

Last Updated: 09/26/2026